Takeda Withdraws European Marketing Authorization Application For Type 2 Diabetes Drug Takeda Pharmaceutical Company Limited announced today that its wholly-owned subsidiary Takeda Global Research & Development Centre (Europe) Ltd. withdrew a European Marketing Authorization Application (MAA) for Competac...